He Wang
Impact in
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
- Microbiology top 5%
- Reproductive tract infections research
Papers in
- Epidemiology 17
- Cervical Cancer and HPV Research 10
- Hepatitis B Virus Studies 2
- Fungal Infections and Studies 2
-
- Inflammasome and immune disorders 2
- Co-authors
- Lin An (1 shared paper)Wei Xia (1 shared paper)Manli Wang (1 shared paper)Peige Song (1 shared paper)Xinlei Chang (1 shared paper)Shanling Liu (7 shared papers)Xin Jin (1 shared paper)Xia‐Nan Wang (1 shared paper)
- Journals
- Infection and Drug Resistance (3 papers)BMC Cancer (3 papers)Frontiers in Pharmacology (2 papers)BMC Microbiology (1 paper)Nano Letters (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
He Wang
64 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 114
- Nephrology 144
- Microbiology 78
- Epidemiology 294
- Transplantation 19
- Cancer Research 106
Countries citing papers authored by He Wang
This map shows the geographic impact of He Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by He Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites He Wang more than expected).
Fields of papers citing papers by He Wang
This network shows the impact of papers produced by He Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by He Wang. The network helps show where He Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside He Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 230 | |
| 2 | 2018 | 140 | |
| 3 | Elevated cleaved caspase-3 is associated with shortened overall survival in several cancer types. | 2014 | 83 |
| 4 | 2019 | 81 | |
| 5 | 2009 | 71 | |
| 6 | 2013 | 54 | |
| 7 | 2006 | 50 | |
| 8 | 2023 | 42 | |
| 9 | 2015 | 39 | |
| 10 | 2018 | 35 | |
| 11 | 2015 | 33 | |
| 12 | 2018 | 29 | |
| 13 | Lin28B is a novel prognostic marker in gastric adenocarcinoma. | 2014 | 29 |
| 14 | 2023 | 26 | |
| 15 | Phospho-histone H2AX is a diagnostic and prognostic marker for epithelial ovarian cancer. | 2015 | 25 |
| 16 | 2012 | 23 | |
| 17 | 1995 | 22 | |
| 18 | 2007 | 22 | |
| 19 | 2018 | 20 | |
| 20 | 2023 | 19 |
About He Wang
He Wang is a scholar working on Epidemiology, Molecular Biology, Oncology, Surgery and Immunology, having authored 67 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (10 papers), Antifungal resistance and susceptibility (3 papers), Osteoarthritis Treatment and Mechanisms (2 papers), Hepatitis B Virus Studies (2 papers), Gout, Hyperuricemia, Uric Acid (2 papers), Fungal Infections and Studies (2 papers), Inflammasome and immune disorders (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Nephrology (144 citations), Microbiology (78 citations), Epidemiology (294 citations), Transplantation (19 citations) and Cancer Research (106 citations). He Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Lin An, Wei Xia, Manli Wang, Peige Song, Xinlei Chang, Shanling Liu, Xin Jin, Xia‐Nan Wang, Diwei Zheng and Xian‐Zheng Zhang. Their work appears in journals such as Infection and Drug Resistance, BMC Cancer, Frontiers in Pharmacology, BMC Microbiology and Nano Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.